ACM
GILD icon

ADAR1 Capital Management’s Gilead Sciences GILD Stock Holding History

ADAR1 Capital Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$587K Sell
4,648
-1,703
-27% -$224K 0.03% 199
2026
Q1 		$885K Sell
6,351
-315
-5% -$44.1K 0.05% 173
2025
Q4 		$818K Buy
+6,666
New +$810K 0.06% 149

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

ADAR1 Capital Management's GILD Position: Q2 2026 in Review

ADAR1 Capital Management reduced its Gilead Sciences (GILD) stake by 27% in Q2 2026, selling an estimated $224K and leaving 4,648 shares worth $587K. The position accounts for 0.03% of the portfolio, ranked #199.

ADAR1 Capital Management first reported a position in GILD in Q4 2025 and has held it in 3 quarters since. The position peaked at $885K in Q1 2026. 2,291 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • ADAR1 Capital Management held 4,648 shares of Gilead Sciences worth $587K as of Q2 2026.
  • ADAR1 Capital Management sold 1,703 Gilead Sciences shares in Q2 2026, an estimated $224K.
  • Gilead Sciences made up 0.03% of ADAR1 Capital Management's portfolio in Q2 2026, its #199 holding.
  • ADAR1 Capital Management first reported a position in Gilead Sciences in Q4 2025 and has held it in 3 quarters since.
  • ADAR1 Capital Management's Gilead Sciences position peaked at $885K in Q1 2026.
  • 2,291 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on ADAR1 Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.